Referred to the Subcommittee on Health.
This resolution expresses Congresss support for National Cystic Fibrosis Awareness Month and related goals, such as promoting early diagnosis, high-quality care, and research. It encourages public awareness and increased support for people with cystic fibrosis and their families but does not create new laws or funding. As a concurrent resolution, it records the views of both chambers and urges action by others without legal force.
Concurrent resolutions are adopted by both the House and the Senate but are not sent to the President and do not have the force of law. They are typically used to express the collective sentiment of Congress or manage internal congressional matters.
This concurrent resolution expresses Congress’s support for National Cystic Fibrosis Awareness Month.
It recounts disease prevalence, improvements in life expectancy, the value of newborn screening and research progress, and calls for public awareness, high-quality care access, and strengthened research through federal commitment and public‑private partnerships.
Concurrent resolution cannot become law; adoption by both chambers is likely but it would not create binding law.
Relative to its intended legislative type, this bill is a straightforward symbolic/concurrent resolution that clearly states the problem and expresses congressional support for awareness, diagnosis, care access, and research regarding cystic fibrosis. It contains the expected minimal operational detail for this type of measure.
Liberals emphasize federal funding and equitable access
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals emphasize federal funding and equitable access
Likely strongly supportive; views the resolution as a useful federal endorsement of awareness, screening, and research.
Sees language about a "strong Federal commitment" and expanded public‑private partnerships as a basis to advocate for more funding and equitable access to care.
Generally favorable; views the resolution as a low‑risk, consensus statement to promote screening and research.
Wants clarity that endorsements are cost‑effective and do not impose unfunded mandates on states.
Generally supportive of awareness and research but cautious about expanding federal obligations.
Prefers emphasis on private‑sector, charitable, and state roles rather than new federal spending or mandates.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Concurrent resolution cannot become law; adoption by both chambers is likely but it would not create binding law.
The bill has not accumulated any surfaced votes yet.
Liberals emphasize federal funding and equitable access
Concurrent resolution cannot become law; adoption by both chambers is likely but it would not create binding law.
Relative to its intended legislative type, this bill is a straightforward symbolic/concurrent resolution that clearly states the problem and expresses congressional support for awareness, diagnosis, care access, and res…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.